Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 3,450 shares at $122.30 ($419K) on 2015-06-05, disclosed to the SEC on 2015-06-08.
Scheduled sale ($419k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.46 | 1,801 | $217K | 51.8% |
| 2 | $122.30 | 1,649 | $202K | 48.2% |
| Total | $121.34 avg | 3,450 | $419K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |